Health officials have given a life-extending drug the green light for widespread NHS, giving hope to thousands of men facing a "death sentence" from prostate cancer.
The National Institute for Health and Care Excellence (Nice) said the drug enzalutamide, also known as xtandi, should be considered for use in the treatment of men with hormone relapsed prostate cancer that has spread to other parts of the body.
Nice said in its draft guidance that it was pleased to recommend the drug, which is manufactured by Astellas Pharma, for patients who have few other treatment options left.
More top news
The Evening Standard airbrushed the singer's braids from its front cover.
The president of the Philippines has offered to shoot criminals while warning he may bring police back to his deadly war on drug addicts.
Malta's government is offering the reward for anyone with information on who killed Malta journalist Caruana Galizia with a car bomb.